Medicago to develop two Ebola antibodies under PHAC contract

Tuesday, Nov 3, 2015 @ 1:10pm by BioPrepWatch Reports

Medicago, Inc., announced last week that they have signed a contract with the Public Health Agency of Canada (PHAC) to develop two antibodies to fight against the Sudan strain of the Ebola virus.
Read More »

Senators introduce bipartisan pandemic protection legislation

Monday, Sep 21, 2015 @ 3:16pm by BioPrepWatch Reports

Bill encourages further measures against biological threats.
Read More »

N.C. governor increases privacy protection of first responders

Friday, Aug 21, 2015 @ 11:05am by BioPrepWatch Reports

North Carolina Gov. Pat McCrory announced on Wednesday that he has enacted a law that will prevent the disclosure of the personal information of first-response personnel and government-issued cell phone numbers.
Read More »

OPCW holds chemical safety and security course for Latin America and Caribbean countries

Thursday, Jun 25, 2015 @ 11:55am by BioPrepWatch Reports

The Organization for the Prohibition of Chemical Weapons (OPCW) said Tuesday it conducted an international course on chemical safety and security management in partnership with the Instituto Nacional de Tecnologia Industrial (INTI) of Argentina.
Read More »

Chemring Detection Systems announces new detector for chemicals, explosives and narcotics

Monday, Jun 22, 2015 @ 5:23pm by BioPrepWatch Reports

Chemring Detection Systems (CDS) has launched the PGR-1064, a handheld device capable of chemical, explosive and narcotic identification, the company announced on Monday.
Read More »

AirBoss acquires Immediate Response Technologies

Thursday, Jun 18, 2015 @ 8:25pm by BioPrepWatch Reports

Air Boss of America Corp. and Immediate Response Technologies LLC. (IRT) have entered into an acquisition agreement, AirBoss announced Wednesday.
Read More »

Study finds bubonic plague host-cell tenet faulty

Friday, Feb 13, 2015 @ 5:16pm by BioPrepWatch Reports

A recent study at the University of North Carolina School of Medicine has shown that the bacteria that cause the bubonic plague do not need to hijack a host cell to travel to the lymph nodes and multiply.
Read More »

Cempra receives $16M from BARDA for drug study

Friday, Nov 21, 2014 @ 1:55pm by BioPrepWatch Reports

Cempra Inc. announced on Thursday that is will receive an additional $16 million from the Biomedical Advanced Research and Development Authority (BARDA) for two more clinical studies of its drug solithromycin on pediatric patients with bacterial infections.
Read More »